Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RXST · against 186 other Healthcare companies of similar size
Ranked #96 of 187 · scores higher than 47% of peers
Bars: peers in each 10-point band of the growth score18 peers with a growth score of 30–39, including RXST · Click a bar to see the companies
Mainly because of its revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
| Metric | RXST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 197 reported | -13.2% | 3.0% | 20% | 33% | |
| Earnings per share growthHigher is better · 74 reported | Not reported | 2.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 182 reported | 23.9% | 2.9% | 81% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 97M USD | 99 | 63 | |
| 5 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 93 | 2.7B CNY (≈$373M) | 40 | 67 | |
| 95 | 171.0B KRW (≈$123M) | 39 | 41 | |
| 96 | 2.0B CNY (≈$284M) | 38 | 34 | |
| 96 | 357M USD | 38 | 32 | |
| 96 | 191M USD | 38 | 38 | |
| 96 | 30.4B INR (≈$365M) | 38 | 39 | |
| 100 | 3.0B SEK (≈$301M) | 37 | 56 | |
| 101 | 1.1B NOK (≈$105M) | 36 | 58 | |
| 102 | 356M AUD (≈$235M) | 35 | 81 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score